Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

Completed

Conditions studied: Hypertension

In brief

To assess the effectiveness of the use of a patient's genes to predict which hypertension therapy is successful

Key facts

Study ID: NCT03292900
Run by: Geneticure, LLC
People needed: 758
Starts: 2018-03-01
Expected to finish: 2019-01-15
Last updated by the study team: 2019-02-15

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Subject is able and willing to provide informed consent
Subject is ≥ 20 and ≤ 85 years of age
Subject with diagnosis of Hypertension for a minimum of 1 year
Subject has been on the same class/classes of blood pressure medication for a minimum of 6 months. Note: A change in dosage, frequency, or specific medication is acceptable as long as there have been no changes to the class/classes of medications prescribed.
Subject with a Body Mass Index (BMI) ≥ 19 and ≤ 45
Subject is currently prescribed and taking one of the following classes of medications alone or in combination with each other.
Diuretics (thiazide or thiazide-like)
ACE Inhibitors
Angiotensin Receptor Blocker (ARB)
Beta-blockers
Ca+ Channel Blockers

You may not qualify if…

Subject has a diagnosis of secondary hypertension or is experiencing a complication of pregnancy.
Subject is currently prescribed and taking any additional class of medication(s) for high blood pressure not included in the list above
Subject has Systolic BP > 190 or Diastolic BP > 120 documented within the six months prior to visit.
Any other reason that the subject is inappropriate for study enrollment in the opinion of the Investigator.

Where it is running

Fairview Clinic - New Brighton — New Brighton, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.